Grace is a young girl living with Lennox-Gastaut Syndrome, a rare and severe type of childhood epilepsy. Before receiving treatment, she endured as many as 400 seizures every single day, severely affecting her growth, learning, and overall quality of life.
In 2015, under medical supervision, Grace began an alternative therapy using cannabidiol (CBD), a compound derived from medical cannabis. The treatment brought significant improvements, offering her relief that conventional medicines had failed to provide.
Her journey — documented closely by her family — has since been highlighted in medical research as an important example of how cannabinoid therapies can help manage drug-resistant epilepsy. The before-and-after contrast in her condition illustrates the profound impact CBD can have on patients like Grace.
Post a Comment